![]() Orum Therapeutics Orum Therapeutics is a biotech company creating cell-penetrating therapeutic antibodies. | ![]() Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. | ||
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2015 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations KR HQ Cambridge, US | Locations South San Francisco, US HQ | Locations Cambridge, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US |
Employees | Employees 512% increase | Employees 49 | Employees 992% decrease | Employees 1133% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 2.8 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income N/A | Net income ($126.3m) (FY, 2022) | Net income ($37.2m) (FY, 2021) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 30m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3.2m (over 15 years ago) |
Total funding raised | Total funding raised $ 38m | Total funding raised $ 72.9m | Total funding raised $ 168.5m | Total funding raised $ 3.2m |

Applied Molecular Transport (AMT) is a biopharmaceutical company.
View company
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyPolyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company